Product Discontinuation definition

Product Discontinuation means a process by which the electrical or mechanical components of a Product become no longer compatible with Product specification or the Product itself will no longer be in mass production. “Last Buy” means the Products that Customer or System Owner purchases from Supplier prior to Product Discontinuation to account for the anticipated rate of defect for such Products.
Sample 1
Product Discontinuation means a process by which the electrical or mechanical components of a Product become no longer compatible with original product or the Product itself will no longer be in mass production.
Sample 1
Product Discontinuation. Vendor shall give Ingram thirty (30) days advance written notice of Product discontinuation. Ingram may return all such Product to Vendor within one hundred eighty (180) days following discontinuation for full credit of Product purchase price plus all freight charges incurred by Ingram in returning the Product.
Sample 1

Examples of Product Discontinuation in a sentence

  • Florida Department of Environmental Protection EXHIBIT G PHOTOGRAPHER RELEASE FORM FOR PHOTOGRAPHS, VIDEOS, AUDIO RECORDINGS AND ARTWORKS DEP AGREEMENT No. R1905 RELEASE FORM FOR PHOTOGRAPHS, VIDEOS, AUDIO RECORDINGS AND ARTWORKS Owner/Submitter’s Name Address City State Zip Phone Number: ( ) Email: License and Indemnification I certify that I am the owner of the photograph(s), video(s), audio recording(s) and/or art work(s) being submitted and am 18 years of age or older.

  • Vendor will remain responsible for all claims during the 180-day notice period unless Vendor’s supplier ceases to offer it for sale.1.6 Product Discontinuation.

  • Table 2 AEs Leading to Dose Modification (Triplet Cohorts) Preferred TermCohort 2 N=3Cohort 3A N=4Cohort 3B N=4Cohort 4 N=24Total Triplet N=35AEs Leading to Investigational Product Discontinuation of any Study TreatmentAny eventBased on data from 20 Oct 2014 cut-off The dose of panitumumab in Cohort 3B and Cohort 4 was 6mg/kg every two weeks.

  • EOT End-of-Treatment; FU Follow-up; IPD Investigational Product Discontinuation; UNS Unscheduled; W Week.

  • Product Discontinuation Notification (PDN) Information: As a minimum, the following information shall be contained in the PDN: ● Reason for product discontinuation.

  • In case of Product Discontinuance, Seller shall provide written notice of planned Product Discontinuation.

  • Per ICHQlO, the goal of Product Discontinuation activities is to "manage the terminal stage of the product lifecycleeffectively."(1) QRM application during product discontinuation activities can serve the following objectives: 根据 ICH Q10，产品退市活动的目的是“有效地管理产品生命周期的最后阶段”。在产品退市活动阶段应用质量风险管理可以达到以下目标： • Ensure risks to patients and product quality continue to be managed while product remains on the market.

  • Product Discontinuation Notification (PDN) Information: As a minimum, the following information shall be contained in the PDN: • Reason for product discontinuation.

  • See Section 2.6 of CMS, FFE and FF-SHOP Enrollment Manual; the “ Reenrollment Communications to Enrollees” section cites CMS guidance: Updated Federal Standard Renewal and Product Discontinuation Notices, September 2016, at https://www.cms.gov/CCIIO/Resources/Regulations-and-Guidance/Downloads/Final-Updated-Federal-Standard-Renewal-and-Product-Discontinuation-Notices-090216.pdf.

  • To comply with this requirement, CMS is publishing this notice.1. Type of Information Collection Request: Revision a currently approved collection; Title of Information Collection: Annual Eligibility Redetermination, Product Discontinuation and Renewal Notices; Use: Section 1411(f)(1)(B) of the Affordable Care Act directs the Secretary of Health and Human Services (the Secretary) to establish proceduresto redetermine the eligibility of individuals on a periodic basis in appropriate circumstances.

Related to Product Discontinuation

  • Practical application means to manufacture in the case of a composition or product, to practice in the case of a process or method, or to operate in the case of a machine or system; and, in each case, under such conditions as to establish that the invention is being utilized and that its benefits are, to the extent permitted by law or government regulations, available to the public on reasonable terms.

  • Recall means any measure aimed at achieving the return of a device that has already been made available to the end user;

  • Recall campaign means the period of time beginning on the

  • Product means any deliverable under the Contract, which may include commodities, services, technology or software.

  • Product Candidate means each of MYO-101, MYO-102, MYO-103, MYO-201 and MYO-301, as defined on Exhibit B, in each case in any form or formulation.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Product Backlog means a list of those Stories that do not form part of the current Sprint Plan at that time and which are to form the subject of a future Sprint, either in the current Release at that time or a subsequent Release;

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Product Labeling means, with respect to a Licensed Product in a country or other jurisdiction in the Territory, (a) the Regulatory Authority-approved full prescribing information for such Licensed Product for such country or other jurisdiction, including any required patient information, and (b) all labels and other written, printed, or graphic matter upon a container, wrapper, or any package insert utilized with or for such Licensed Product in such country or other jurisdiction.

  • Medical evaluation means the process of assessing an individual's health status that includes a medical history and a physical examination of an individual conducted by a licensed medical practitioner operating within the scope of his license.

  • Clinical Studies means Xxxxx 0, Xxxxx 0, Xxxxx 0, Xxxxx 3, and such other tests and studies in human subjects that are required by Applicable Law, or otherwise recommended by the Regulatory Authorities, to obtain or maintain Regulatory Approvals for a Licensed Product for one (1) or more indications, including tests or studies that are intended to expand the Product Labeling for such Licensed Product with respect to such indication.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Product Complaint means any oral, electronic or written communication that alleges deficiencies related to the identity, quality, durability, reliability, safety, effectiveness or performance of a marketed product, including failure of the product, labelling or packaging to meet specifications, whether or not the product is related to or caused the alleged deficiency. A complaint may allege that an Adverse Event or Medical Device Malfunction (as defined herein) has occurred.

  • FDA Approval means with respect to the Product, a Regulatory Approval by the FDA for the commercial use of the Product in the United States.

  • Product Group or “the Group” means a group of lotteries that has joined together to offer a product pursuant to the terms of the Multi-State Lottery Agreement and the Product Group’s own rules.

  • Direction-indicator lamp means the lamp used to indicate to other road-users that the driver intends to change direction to the right or to the left;

  • Communicable disease means an illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.

  • Practical examination means a demonstration through application of the safety rules and principles in industrial radiography including use of all procedures and equipment to be used by radiographic personnel.

  • Table of Product Details means the table attached to these Terms and Conditions which contains the definitions in relation to each series of Securities.

  • Alternative nicotine product means any vaping product, whether or not it includes nicotine, including electronic smoking devices, that can be ingested into the body by chewing, smoking, absorbing, dissolving, inhaling, or by any other means. ‘Alternative nicotine product’ does not include:

  • Automatic disconnect means a device that when triggered, conductively separates the electric energy sources from the rest of the high voltage circuit of the electric power train.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.